MENU
+Compare
UPC
Stock ticker: NASDAQ
AS OF
Mar 10, 04:59 PM (EDT)
Price
$0.13
Change
-$0.00 (-0.00%)
Capitalization
7.98M

UPC Universe Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being... Show more

UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for UPC with price predictions
Mar 07, 2025

UPC in +5.12% Uptrend, growing for three consecutive days on March 05, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UPC advanced for three days, in of 167 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UPC's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on UPC as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UPC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for UPC entered a downward trend on March 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.202) is normal, around the industry mean (60.305). P/E Ratio (3.000) is within average values for comparable stocks, (90.174). UPC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.246) is also within normal values, averaging (20.030).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. UPC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UPC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
265 Jingjiu Avenue
Phone
+86 7968403309
Employees
225
Web
http://www.universe-pharmacy.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLNH1.030.08
+8.42%
Soluna Holdings
NAUT1.200.06
+5.26%
Nautilus Biotechnolgy
BRC71.611.88
+2.70%
Brady Corp
RTO22.950.30
+1.32%
Rentokil Initial plc
AC36.38-0.11
-0.30%
Associated Capital Group

UPC and Stocks

Correlation & Price change

A.I.dvisor tells us that UPC and DRRX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UPC and DRRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UPC
1D Price
Change %
UPC100%
+9.03%
DRRX - UPC
27%
Poorly correlated
+0.05%
TXMD - UPC
22%
Poorly correlated
+1.20%
CRON - UPC
13%
Poorly correlated
-1.00%
ASRT - UPC
13%
Poorly correlated
-3.47%
CGC - UPC
12%
Poorly correlated
N/A
More